Animal cells and systems

The Korean Society for Integrative Biology (한국통합생물학회)
권호 표지
DOI QR코드

DOI QR Code

Phosphoinositide 3-kinase regulates myogenin expression at both the transcriptional and post-transcriptional level during myogenesis

  • Woo, Joo-Hong (Department of Biological Science, College of Natural Sciences, Ajou University) ;
  • Kim, Min-Jeong (Department of Biological Science, College of Natural Sciences, Ajou University) ;
  • Kim, Hye-Sun (Department of Biological Science, College of Natural Sciences, Ajou University)
  • Received : 2010.01.26
  • Accepted : 2010.05.25
  • Published : 2010.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

It is well-established that phosphoinositide 3-kinase (PI3-kinase) regulates myogenesis by inducing transcription of myogenin, a key muscle regulatory factor, at the initiation of myoblast differentiation. In this study, we investigated the role of PI3-kinase in cells that have committed to differentiation. PI3-kinase activity increases during myogenesis, and this increase is sustained during the myogenic process; however, its function after the induction of differentiation has not been investigated. We show that LY294002, a PI3-kinase inhibitor, blocked myoblast fusion even after myogenin expression initially increased. In contrast to the inhibitory effects of LY294002 on myogenin mRNA levels during the initiation of differentiation, LY294002 blocked the accumulation of myogenin protein without affecting its mRNA level after differentiation was induced. Treatment with cycloheximide, a translation inhibitor, or actinomycin D, a transcription inhibitor, indicated that the stability of myogenin protein is lower than that of its mRNA. LY294002 inhibited the activities of several important translation factors, including eukaryotic elongation factor-2(eEF2), by altering their phosphorylation status. In addition, LY294002 blocked the incorporation of [$^{35}S$]methionine into newly synthesized proteins. Since myogenin has a relatively short half-life, LY294002-mediated inhibition of post-transcriptional processes resulted in a rapid depletion of myogenin protein. In summary, these results suggest that PI3-kinase plays an important role in regulating the expression of myogenin through post-transcriptional mechanisms after differentiation has been induced.

Keywords

References

  1. Alvarez B, Garrido E, Garcia-Sanz JA, Carrera AC. 2003. Phosphoinositide 3-kinase activation regulates cell division time by coordinated control of cell mass and cell cycle progression rate. J Biol Chem. 278:26466-26473. https://doi.org/10.1074/jbc.M300663200
  2. Arnold HH, Braun T. 1996. Targeted inactivation of myogenic factor genes reveals their role during mouse myogenesis: a review. Int J Dev Biol. 40:345-363.
  3. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. 1990. The protein Id: a negative regulator of helixloop- helix DNA binding proteins. Cell. 61:49-59. https://doi.org/10.1016/0092-8674(90)90214-Y
  4. Brand-Saberi B, Christ B. 1999. Genetic and epigenetic control of muscle development in vertebrates. Cell Tissue Res. 296:199-212. https://doi.org/10.1007/s004410051281
  5. Browne GJ, Proud CG. 2002. Regulation of peptidechain elongation in mammalian cells. Eur J Biochem. 269:5360-5368. https://doi.org/10.1046/j.1432-1033.2002.03290.x
  6. Edmondson DG, Olson EN. 1989. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev. 3:628-640. https://doi.org/10.1101/gad.3.5.628
  7. Edmondson DG, Brennan TJ, Olson EN. 1991. Mitogenic repression of myogenin autoregulation. J Biol Chem. 266:21343-21346.
  8. Edwards DR, Mahadevan LC. 1992. Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms: lack of evidence for labile repressors. EMBO J. 11:2415-2424.
  9. Emerson CP. 1990. Myogenesis and developmental control genes. Curr Opin Cell Biol. 2:1065-1075. https://doi.org/10.1016/0955-0674(90)90157-A
  10. Figueroa A, Cuadrado A, Fan J, Atasoy U, Muscat GE, Munoz-Canoves P, Gorospe M, Munoz A. 2003. Role of HuR in skeletal myogenesis through coordinate regulation of muscle differentiation genes. Mol Cell Biol. 23:4991-5004. https://doi.org/10.1128/MCB.23.14.4991-5004.2003
  11. Franch HA, Sooparb S, Du J. 2001. A mechanism regulating proteolysis of specific proteins during renal tubular cell growth. J Biol Chem. 276:19126-19131. https://doi.org/10.1074/jbc.M101777200
  12. Franch HA, Wang X, Sooparb S, Brown NS, Du J. 2002. Phosphatidylinositol 3-kinase activity is required for epidermal growth factor to suppress proteolysis. J Am Soc Nephrol 13:903-909.
  13. Gharbi SI, Zvelebil MJ, Shuttleworth SJ, Hancox T, Saghir N, Timms JF, Waterfield MD. 2007. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J. 404:15-21. https://doi.org/10.1042/BJ20061489
  14. Giorgino F, Pedrini MT, Matera L, Smith RJ. 1997. Specific increase in p85alpha expression in response to dexamethasone is associated with inhibition of insulinlike growth factor-I stimulated phosphatidylinositol 3- kinase activity in cultured muscle cells. J Biol Chem. 272:7455-7463. https://doi.org/10.1074/jbc.272.11.7455
  15. Hay N, Sonenberg N. 2004. Upstream and downstream of mTOR. Genes Dev. 18:1926-1945. https://doi.org/10.1101/gad.1212704
  16. Herbert GB, Shi B, Gartenhaus RB. 2001. Expression and stabilization of the MCT-1 protein by DNA damaging agents. Oncogene. 20:6777-6783. https://doi.org/10.1038/sj.onc.1204881
  17. Jeon YJ, Kim HS, Kim HS, Kang MS, Chung CH, Ha DB. 1994. The 100-kDa protein, whose phosphorylation precedes the fusion of chick embryonic myoblasts, is the eukaryotic elongation factor-2. Biochem Biophys Res Commun. 198:132-137. https://doi.org/10.1006/bbrc.1994.1019
  18. Jiang BH, Zheng JZ, Vogt PK. 1998. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. Proc Natl Acad Sci USA. 95:14179-14183. https://doi.org/10.1073/pnas.95.24.14179
  19. Kaliman P, Vinals F, Testar X, Palacin M, Zorzano A. 1996. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem. 271:19146- 19151. https://doi.org/10.1074/jbc.271.32.19146
  20. Knebel A, Morrice N, Cohen P. 2001. A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta. EMBO J. 20:4360-4369. https://doi.org/10.1093/emboj/20.16.4360
  21. Lassar A, Munsterberg A. 1994. Wiring diagrams: regulatory circuits and the control of skeletal myogenesis. Curr Opin Cell Biol. 6:434-442.
  22. Li H, Choudhary SK, Milner DJ, Munir MJ, Kuisk IR, Capetanaki Y. 1994. Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogenin. J Cell Biol. 124:827-841. https://doi.org/10.1083/jcb.124.5.827
  23. Lopez-Carballo G, Moreno L, Masia S, Perez P, Barettino D. 2002. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem. 277:25297-25304. https://doi.org/10.1074/jbc.M201869200
  24. McVean M, Xiao H, Isobe K, Pelling JC. 2000. Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. Carcinogenesis. 21:633-639. https://doi.org/10.1093/carcin/21.4.633
  25. Molkentin JD, Olson EN. 1996. Defining the regulatory networks for muscle development. Curr Opin Genet Dev. 6:445-453. https://doi.org/10.1016/S0959-437X(96)80066-9
  26. Nakanishi S, Kakita S, Takahashi I, Kawahara K, Tsukuda E, Sano T, Yamada K, Yoshida M, Kase H, Matsuda Y. 1992. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J Biol Chem. 267:2157-2163.
  27. Olson EN. 1990. MyoD family: a paradigm for development? Genes Dev. 4:1454-1461. https://doi.org/10.1101/gad.4.9.1454
  28. Perry RL, Rudnick MA. 2000. Molecular mechanisms regulating myogenic determination and differentiation. Front Biosci. 5:D750-767. https://doi.org/10.2741/Perry
  29. Proud CG. 2004. Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy. Cardiovasc Res. 63:403-413. https://doi.org/10.1016/j.cardiores.2004.02.003
  30. Ruvinsky I, Meyuhas O. 2006. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci. 31:342-348. https://doi.org/10.1016/j.tibs.2006.04.003
  31. Ryazonov AG, Davydova EK. 1989. Mechanism of elongation factor 2 (EF-2) inactivation upon phosphorylation. Phosphorylated EF-2 is unable to calalyze translocation. FEBS Lett 251:187-190. https://doi.org/10.1016/0014-5793(89)81452-8
  32. Sarker KP, Lee KY. 2004. L6 myoblasts differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathway. Oncogene. 23:6064-6070. https://doi.org/10.1038/sj.onc.1207819
  33. Shen WH, Boyle DW, Wisniowski P, Bade A, Liechty EA. 2005. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids. J Endocrinol. 185:275-289. https://doi.org/10.1677/joe.1.06080
  34. Song A, Wang Q, Goebl MG, Harrington MA. 1998. Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol Cell Biol. 18:4994-4998.
  35. Sun H, Xu B, Sheveleva E, Chen QM. 2008. LY294002 inhibits glucocorticoid-induced COX-2 gene expression in cardiomyocytes through a phosphatidylinositol 3 kinase-independent mechanism. Toxicol Appl Pharmacol. 232:25-32.
  36. Thayer MJ, Tapscott SJ, Davis RL, Wright WE, Lassar AB, Weintraub H. 1989. Positive autoregulation of the myogenic determination gene MyoDl. Cell. 58:241-248. https://doi.org/10.1016/0092-8674(89)90838-6
  37. Vanhaesebroeck B, Waterfield MD. 1999. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res. 253:239-254. https://doi.org/10.1006/excr.1999.4701
  38. Vin˜ als F, Ventura F. 2004. Myogenin protein stability is decreased by BMP-2 through a mechanism implicating Id1. J Biol Chem. 279:45766-45772. https://doi.org/10.1074/jbc.M408059200
  39. Wang L, Wang X, Proud CG. 2000. Activation of mRNA translation in rat cardiac myocytes by insulin involves multiple rapamycin-sensitive steps. Am J Physiol Heart Circ Physiol. 278(4):H1056-1068.
  40. Wang X, Li W, William M, Terada N, Alessi DR, Proud CG. 2001. Regulation of elongation factor 2 kinase by p90 (RSK1) and p70 kinase. EMBO J. 20:4370-4379. https://doi.org/10.1093/emboj/20.16.4370
  41. Weintraub H, Davis R, Tapscott S, Thayer M, Krause M, Benezra R, Blackwell T, Turner D, Rupp R, Hollenberg S. 1991. The myoD gene family: nodal point during specification of the muscle cell lineage. Science. 251:761- 766. https://doi.org/10.1126/science.1846704
  42. Wilson GM, Roberts EA, Deeley RG. 1997. Modulation of LDL receptor mRNA stability by phorbol esters in human liver cell culture models. J Lipid Res. 38:437-446.
  43. Wright WE, Sassoon DA, Lin VK. 1989. Myogenin, a factor regulating myogenesis, has a domain homologous to myoD1. Cell. 56:607-617.
  44. Woo JH, Kim HS. 2006. Phosphorylation of eukaryotic elongation factor 2 can be regulated by phosphoinositide 3-kinase in the early stages of myoblast differentiation. Mol Cells. 21:294-301.
  45. Woo JH, Kim JH, Mook-Jung I, Kim HS. 2006. Lipid products of phosphoinositide 3-kinase abrogate genistein- induced fusion inhibition in myoblasts. Eur J Pharmacol. 529:84-94. https://doi.org/10.1016/j.ejphar.2005.11.007
  46. Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, Nonomura Y, Matsuda Y. 1993. Inhibition of histamine secretion by wortmannin through blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem. 268:25846-25856.

Cited by

  1. Effects of MicroRNA-27a on Myogenin Expression and Akt/FoxO1 Signal Pathway during Porcine Myoblast Differentiation vol.29, pp.3, 2010, https://doi.org/10.1080/10495398.2017.1348357